Navigation Links
Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males
Date:7/2/2009

PHOENIX, July 2 /PRNewswire/ -- As many as five to ten million males in the U.S. struggle quietly with an eating disorder because they're ashamed to admit they have the illness, reports Remuda Ranch Programs for Eating and Anxiety Disorders. Healthcare professionals, family members and close friends often are unaware of the high-risk behaviors in males that may signify an eating disorder. Therefore, effective intervention is often not available to the male population.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090604/CG27861LOGO

"It is a reality that boys and men do have eating disorders and ignoring the problem may only allow it to get to a life threatening state," said Sam Lample, therapist and assistant clinical director of ReddStone, A Remuda Program for Boys. "Early and proper diagnosis from healthcare providers could be a powerful force in preventing male eating disorders from becoming as common as they have become in females."

ReddStone is an inpatient program that treats boys 17 and under who are struggling with anorexia, bulimia and binge-eating disorder. It follows the Remuda Model of Treatment that is based on a bio-psycho-social-spiritual framework. The program doesn't just treat the disorder; it treats the entire patient and offers them the best possible chance for complete and lasting recovery from eating disorders.

Research suggests that at least 1 in 4 pre-teen cases of anorexia are male. There are thousands of males with eating disorders in our society. Historically, it was thought that the ratio of boys to girls with eating disorders was 1:10, but more recent research indicates that it may be closer to 1:3.

"Over the past 10 years, the male body has come under much scrutiny, much like the female body has for decades," adds Lample. "Boys see images in the media and are inundated with the message that they need to look that way or they're inadequate."

At ReddStone, Boys remain in treatment for 60 days - the minimum amount of time required for eating disorder behaviors to stop and new skills to be acquired. Each boy has a team of professionals, who not only treat the eating disorder, but address co-occurring issues such as depression, anxiety, substance abuse and trauma.

Since 1990, Remuda has provided care to nearly 9,000 patients with eating disorders. Ninety-five percent of Remuda's patients are in good recovery one, five and ten years after leaving the program. They no longer have a diagnosable eating disorder, their personal relationships have improved and they're functioning more effectively in school and work.

About Remuda Ranch Programs for Eating and Anxiety Disorders

Remuda Ranch offers Christian inpatient and residential programs for individuals of all faiths suffering from eating or anxiety disorders. Each patient is treated by a multi-disciplinary team including a Psychiatric and a Primary Care Provider, Registered Dietitian, Masters Level therapist, Psychologist and Registered Nurse. The professional staff equips each patient with the right tools to live a healthy, productive life. For more information, call 1-800-445-1900 or visit www.remudaranch.com.


'/>"/>
SOURCE Remuda Ranch Programs for Eating and Anxiety Disorders
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
2. Tryton Medical Receives CE Mark Approval for its Side-Branch Stent
3. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
4. Environmental Operating Solutions Completes Initial Tranche of $2.5 Million Institutional Financing
5. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
6. Amarin Announces Completion of the First Tranche of $60 Million Private Placement
7. Tree branching key to efficient flow in nature and novel materials
8. Stunning Attendance for ChemOutsourcing Show on September 8-9 in Long Branch, NJ
9. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
10. Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing
11. Intradigm Closes Final Tranche of $21.4 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and ... is a fully 21 CFR Part 11-compliant email client designed to provide product ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... of Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading ... grant applications subject to the existing policy. AMIA recommended that NIH earmark funding ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a go-getter type ... tremendous growth is accounted to two main factors. The first is the amazing ... of vendors supplying FireflySci products all around the world. , 2016 was a tremendous ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., a ... scanning technology for automotive at CES® 2017. Delta ID ... ) to demonstrate the use of iris scanning as ... authenticate the driver in a car, and as a ... driving experience. Delta ID and Gentex will ...
(Date:12/22/2016)... -- As part of its longstanding mission to improve genetic literacy ... released its latest children,s book, titled The One ... topics of inheritance and variation of traits that are part ... school classrooms in the US. The book ... Killoran , whose previous book with 23andMe, You ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
Breaking Biology News(10 mins):